These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 16778979)
1. [Fecal calprotectin in differential diagnosis of irritable bowel syndrome]. Li XG; Lu YM; Gu F; Yang XL Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):310-3. PubMed ID: 16778979 [TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Menees SB; Powell C; Kurlander J; Goel A; Chey WD Am J Gastroenterol; 2015 Mar; 110(3):444-54. PubMed ID: 25732419 [TBL] [Abstract][Full Text] [Related]
3. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome. Sydora MJ; Sydora BC; Fedorak RN J Crohns Colitis; 2012 Mar; 6(2):207-14. PubMed ID: 22325175 [TBL] [Abstract][Full Text] [Related]
4. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms. Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083 [TBL] [Abstract][Full Text] [Related]
5. Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study. David LE; Surdea-Blaga T; Dumitrascu DL Sao Paulo Med J; 2015; 133(4):343-9. PubMed ID: 26039537 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome. Otten CM; Kok L; Witteman BJ; Baumgarten R; Kampman E; Moons KG; de Wit NJ Clin Chem Lab Med; 2008; 46(9):1275-80. PubMed ID: 18597588 [TBL] [Abstract][Full Text] [Related]
7. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166 [TBL] [Abstract][Full Text] [Related]
8. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome. Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223 [TBL] [Abstract][Full Text] [Related]
9. [Fecal calprotectin concentration in the differential diagnosis of bowel diseases]. Osipenko MF; Livzan MA; Skalinskaya MI; Lyalyukova EA Ter Arkh; 2015; 87(2):30-33. PubMed ID: 25864345 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Dolwani S; Metzner M; Wassell JJ; Yong A; Hawthorne AB Aliment Pharmacol Ther; 2004 Sep; 20(6):615-21. PubMed ID: 15352909 [TBL] [Abstract][Full Text] [Related]
11. Clinical utility of the assessment of fecal calprotectin in Leśniowski-Crohn's disease. Eder P; Stawczyk-Eder K; Krela-Kaźmierczak I; Linke K Pol Arch Med Wewn; 2008 Nov; 118(11):622-6. PubMed ID: 19140565 [TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease. Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229 [TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings. Hradsky O; Ohem J; Mitrova K; Durilova M; Kotalova R; Nevoral J; Kolho KL; Bronsky J Clin Lab; 2014; 60(12):1993-2000. PubMed ID: 25651733 [TBL] [Abstract][Full Text] [Related]
14. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease. Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672 [TBL] [Abstract][Full Text] [Related]
15. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders. Caviglia GP; Pantaleoni S; Touscoz GA; Adriani A; Rosso C; Smedile A; Pellicano R; Astegiano M; Bresso F Scand J Gastroenterol; 2014 Dec; 49(12):1419-24. PubMed ID: 25369978 [TBL] [Abstract][Full Text] [Related]
16. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease. Grad C; David L; Portincasa P; Dumitraşcu DL Rom J Intern Med; 2012; 50(1):3-6. PubMed ID: 22788087 [TBL] [Abstract][Full Text] [Related]
18. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327 [TBL] [Abstract][Full Text] [Related]
19. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461 [TBL] [Abstract][Full Text] [Related]
20. Accuracy of four fecal assays in the diagnosis of colitis. Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]